Imunon to host R&D day on Phase 3 ovarian cancer trial in September
Tweet Send to a Friend
Imunon, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company, announced it will host an R&D Day on September 23, 2026, at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
